Clinical trials
Observational Choroidal Neovascularization trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Notal Vision Ltd. | 3 |
| National Eye Institute (NEI) | 2 |
| Adverum Biotechnologies, Inc. | 1 |
| Johns Hopkins University | 1 |
| Michael Abramoff | 1 |
| Oklahoma State University Center for Health Sciences | 1 |
| Sequenom, Inc. | 1 |
| University of Utah | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Choroidal Neovascularization | 11 |
| Macular Degeneration | 10 |
| Blindness | 1 |
| Central Serous Chorioretinopathy | 1 |
| Eye Diseases | 1 |
| Geographic Atrophy | 1 |
| Ornithine Carbamoyltransferase Deficiency Disease | 1 |
| Retinal Degeneration | 1 |
| Retinal Diseases | 1 |
| Wet Macular Degeneration | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.